Most Recent
David Jones enters administration after talks with landlord break down
Rising costs and evolving shopping trends have forced 188-year-old department store David Jones into voluntary administration, a day after its landlord revealed the retailer had not paid rent since September.
Bolton loses bid for High Court hearing in Keybridge indemnity case
Pointing to the "litigious history" of the case, the High Court has refused leave to former Keybridge Capital director Nick Bolton to appeal a decision that found the company wasn't on the hook for covering his legal bill in a case over alleged duty breaches.
Solicitor was employee of firm, despite contractor agreement: FWC
The Fair Work Commission has found that a solicitor who entered into a contract akin to an independent contractor agreement with Linkpoint Lawyers was an employee of the firm.
Construction PRO
GB Energy falls into administration amid project delays
The company behind the $1 billion Golden Beach gas storage project in Gippsland has fallen into administration, a fortnight after the Victorian government approved its licence.
Construction PRO
Cranbrook loses bid to force retirement village sale negotiations
Retirement village owner Milstern was not obligated to exclusively negotiate with Sydney property developer Cranbrook for the sale of five of its villages, a judge has found in refusing to make orders blocking Milstern from talks with an alternative bidder.
Construction PRO
Warburg Pincus makes fifth offer for Ingenia Communities
The bidding war for property developer Ingenia Communities continues, with private equity firm Warburg Pincus on Friday besting an offer made five days earlier by AVID Property Group.
Construction PRO
ATO wants split trial in case over $300M Esso, Woodside tax bill
The Tax Office wants to hive off a contract dispute between Japanese conglomerate Mitsui and its Kipper gas field partners Esso and Woodside in a fight over a $298 million tax bill.
Mayne Pharma divests international segment for $55.5M in US pivot
Mayne Pharma has agreed to sell its international unit to Evaris Pharma for $55.5 million, completing the South Australian company's pivot to a US-focused specialty pharmaceutical company.
Gilead settles with Alphapharm in patent suit over HIV drugs
A settlement has been reached in patent litigation brought by US biopharmaceutical company Gilead Sciences against generic drug maker Alphapharm over plans for a cheap version of Gilead's HIV drugs.
FWC finds dismissal of CBA home loan exec was ‘sound’
The FWC has found that Commonwealth Bank’s dismissal of a home loan executive was justified, after an investigation revealed WeChat communications with a third party who was receiving payments from CBA customers.